Latest Insurance News

Lumos Diagnostics reported a 12% revenue increase for FY25 and inked a landmark US$317 million exclusive distribution deal for its FebriDx test, while advancing its FDA CLIA waiver application.

Connexion Mobility reported steady revenue growth and a 7% increase in net profit before tax for Q4 FY25, driven by expanding SaaS subscriptions and strategic product enhancements.

TAL Dai-ichi Life Australia has obtained all necessary regulatory approvals, including from APRA, to finalize its minority investment in Challenger Limited, acquiring a 19.9% equity stake.

Mesoblast has reported a strong commercial debut for Ryoncil, the first FDA-approved mesenchymal stromal cell therapy for pediatric steroid-refractory acute graft-versus-host disease, generating US$13.2 million in gross revenue in its initial quarter. The company is advancing regulatory and clinical milestones while expanding insurance coverage across the US.

Mirrabooka Investments reports a 26% drop in net profit for FY25 but maintains its fully franked dividend, supported by a significant $85 million capital raise. The fund’s portfolio return lags the benchmark amid sector headwinds, yet long-term performance remains robust.

29Metals Limited's June Quarter 2025 report highlights steady production at Golden Grove with revised capital guidance, while Capricorn Copper remains suspended but progresses on key environmental and regulatory fronts.

29Metals Limited reported a stronger June quarter with increased copper production at Golden Grove, offset by higher costs and deferred capital spending on the Gossan Valley project. The company also secured a final $54 million insurance payout and improved liquidity despite ongoing operational challenges at Capricorn Copper.

Spectur Ltd reports a stronger cash position driven by operational improvements and strategic cloud investments, while FY25 revenue slightly misses guidance due to delayed orders.

Telix Pharmaceuticals has achieved a key milestone with its next-generation prostate cancer imaging agent, Gozellix, receiving a permanent HCPCS code from U.S. Medicare. This paves the way for broader reimbursement and market adoption starting October 2025.

DigitalX has raised $20.7 million from leading global digital asset investors to expand its Bitcoin holdings and reinforce its position as a Bitcoin-focused investment manager.

AMP Limited is set to defend itself against a new class action alleging inflated life insurance premiums and a separate dispute over a major property sale, signaling potential challenges ahead for the financial services giant.

Keybridge Capital has obtained a $9.3 million bridge funding facility from Active Asset Management, supported by an ASX waiver allowing the deal without prior shareholder approval. The funding aims to address urgent liquidity and solvency challenges while trading remains suspended.